These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3327892)

  • 1. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F; Margonato A; Ceccardi R; Rigatti P; Rossini BM
    Urol Res; 1982; 10(3):131-4. PubMed ID: 6182672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].
    Ghaddar Y; Caissel J; Léandri P; Rossignol G
    Ann Urol (Paris); 1987; 21(2):107-14. PubMed ID: 2441642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E; Recalcati P; Tantalo V; Bregnani P
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
    Forette F; Varin D; Henry JF; Hervy MP
    Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A; Liverta C; Pollini C
    Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of nicergoline on the intellectual performance (author's transl)].
    Donoso A; Santander M; Sarce H
    Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
    [No Abstract]   [Full Text] [Related]  

  • 11. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
    Bossi L
    Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Prog Clin Biol Res; 1981; 78():269-75. PubMed ID: 6174998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
    Battaglia A; Bruni G; Ardia A; Sacchetti G
    J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of nicergoline (Sermion) in the treatment of migraine].
    Prusiński A; Durko A; Selmaj K
    Wiad Lek; 1984 Mar; 37(6):420-2. PubMed ID: 6385484
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
    Marolda M; Fragassi N; Buscaino GA
    Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma].
    Dufour B; Choquenet C; Revol M; Faure G; Jorest R
    Ann Urol (Paris); 1984 May; 18(3):193-5. PubMed ID: 6084978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relaxing effect of nicergoline on the female urethra in peripheral neurogenic vesicosphincter dysfunctions].
    Galas JM; Grillot MJ; Vasse MG; Vaillandet M; Guillemin P
    J Urol (Paris); 1984; 90(8-9):563-5. PubMed ID: 6398829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis.
    Bousquet J; Rivory JP; Maheut M; Michel FB; Mion C
    J Allergy Clin Immunol; 1989 Apr; 83(4):825-8. PubMed ID: 2708742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.